We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MNTN:NYSEMNTN, Inc. Analysis

Data as of 2026-05-27 - not real-time

$9.11

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MNTN posted a robust 14% year‑over‑year revenue growth and maintains an impressive gross margin of nearly 80%, while its operating margin sits at 13% and net profit margin above 7%. The stock trades at a PE of 6.6, dramatically lower than the software industry average of 40, and the DCF model suggests a fair value of $16.6, implying more than 100% upside from the current $9.11 price. Technicals show a bearish trend with price below the 20‑day SMA, decreasing volume, and a support level around $7.67, yet the MACD histogram turned positive and the RSI is neutral at 53. Recent earnings beat revenue guidance and highlighted strong cash conversion, but the share price slipped about 10% after the announcement, reflecting short‑term investor disappointment. High beta (1.3) and a 30‑day volatility near 96% underscore significant price swings, while the company’s balance sheet is solid with $214 M cash and zero debt. Overall, the fundamentals are compelling, but the market remains jittery, suggesting a cautious but optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat but price fell 10% post‑announcement
  • Technical bearish trend with decreasing volume
  • Support level near $7.67 offering limited downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 14% and high gross margins
  • Valuation gap: PE 6.6 vs industry 40 and >100% upside to DCF fair value
  • Strong cash position and zero debt supporting scalability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Expanding Connected TV advertising market
  • Sustainable profitability and cash conversion
  • Undervaluation relative to long‑term growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin7.83%
P/E Ratio6.6
ROE12.55%
ROA8.30%
P/B Ratio2.1
Op. Cash Flow$61.6M
Free Cash Flow$-7579750
Industry P/E40.1

Technical Analysis

TrendBearish
RSI53.3
Support$7.67
Resistance$11.39
MA 20$8.82
MA 50$9.10
MA 200$13.13
MACDBullish
VolumeDecreasing
Fear & Greed Index91.29

Valuation

Fair Value$16.63
Target Price$20.00
Upside/Downside119.54%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.30
Volatility95.95%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.